What is the address of DEPRETZ SEVERINE INFIRMIERE?

The registered office of DEPRETZ SEVERINE INFIRMIERE is located at Rue du Palais (POT) 35, 7760 Celles (lez-Tournai).

Is DEPRETZ SEVERINE INFIRMIERE still active?

Yes. According to the CBE (16 September 2026) DEPRETZ SEVERINE INFIRMIERE is active, legal situation “Normale toestand”, started on 14 December 2021.

Is DEPRETZ SEVERINE INFIRMIERE registered on Peppol?

Yes, DEPRETZ SEVERINE INFIRMIERE is registered on the Peppol network with ID 0208:0778630084.

What is the enterprise number of DEPRETZ SEVERINE INFIRMIERE?

The enterprise number of DEPRETZ SEVERINE INFIRMIERE is BE0778630084.

When was DEPRETZ SEVERINE INFIRMIERE founded?

DEPRETZ SEVERINE INFIRMIERE was founded on 14 December 2021.

Who are the directors of DEPRETZ SEVERINE INFIRMIERE?

According to the 2025 annual accounts, the directors of DEPRETZ SEVERINE INFIRMIERE are: SEVERINE DEPRETZ.

Is DEPRETZ SEVERINE INFIRMIERE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 14 December 2021; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DEPRETZ SEVERINE INFIRMIERE make in 2025?

DEPRETZ SEVERINE INFIRMIERE posted a profit after taxes of € 10,564 in financial year 2025.

What is the revenue of DEPRETZ SEVERINE INFIRMIERE?

As a small company, DEPRETZ SEVERINE INFIRMIERE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 18,493.

DEPRETZ SEVERINE INFIRMIERE (Private Limited)

Dossier DEPRETZ SEVERINE INFIRMIERE, printed on 16 September 2026 from databakkes.be/en/0778630084/depretz-severine-infirmiere. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DEPRETZ SEVERINE INFIRMIERE from Celles (lez-Tournai), company number BE0778630084, closed financial year 2025 with a result of € 10,564 after tax. For that financial year DEPRETZ SEVERINE INFIRMIERE recorded a gross margin of € 18,493 and equity of € 4,285. Compared with financial year 2024, the result moved from € 13,347 to € 10,564. The company is profitable. The buffer shrank hard: equity is 87 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on March 2, 2026.

What it is worth Shrank hard

€ 4,285

▼ 87% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 10,564

▼ 21% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 40,312

▲ 35% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 40,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 187

▼ 58% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,895

▲ 4% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 6,650

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 30,380 Gross margin 2022: € 30,380 First fiscal year in the series	€ 11,915 Gross margin 2023: € 11,915 ▼ 61% vs 2022 (€ 30,380) Unfavourable step	€ 21,607 Gross margin 2024: € 21,607 ▲ 81% vs 2023 (€ 11,915) Favourable step	€ 18,493 Gross margin 2025: € 18,493 ▼ 14% vs 2024 (€ 21,607) Unfavourable step	▼ 14%
Profit after taxes	€ 16,351 Profit after taxes 2022: € 16,351 First fiscal year in the series	€ 2,023 Profit after taxes 2023: € 2,023 ▼ 88% vs 2022 (€ 16,351) Unfavourable step	€ 13,347 Profit after taxes 2024: € 13,347 ▲ € 11,324 vs 2023 (€ 2,023) Favourable step	€ 10,564 Profit after taxes 2025: € 10,564 ▼ 21% vs 2024 (€ 13,347) Unfavourable step	▼ 21%
Equity	€ 18,351 Equity 2022: € 18,351 First fiscal year in the series	€ 20,374 Equity 2023: € 20,374 ▲ 11% vs 2022 (€ 18,351) Favourable step	€ 33,721 Equity 2024: € 33,721 ▲ 66% vs 2023 (€ 20,374) Favourable step	€ 4,285 Equity 2025: € 4,285 ▼ 87% vs 2024 (€ 33,721) Unfavourable step	▼ 87%
Total debts	€ 17,804 Total debts 2022: € 17,804 First fiscal year in the series	€ 10,280 Total debts 2023: € 10,280 ▼ 42% vs 2022 (€ 17,804) Favourable step	€ 4,252 Total debts 2024: € 4,252 ▼ 59% vs 2023 (€ 10,280) Favourable step	€ 44,885 Total debts 2025: € 44,885 ▲ € 40,633 vs 2024 (€ 4,252) Unfavourable step	▲ € 40,633
Cash	€ 15,321 Cash 2022: € 15,321 First fiscal year in the series	€ 14,923 Cash 2023: € 14,923 ▼ 3% vs 2022 (€ 15,321) Unfavourable step	€ 29,864 Cash 2024: € 29,864 ▲ 100% vs 2023 (€ 14,923) Favourable step	€ 40,312 Cash 2025: € 40,312 ▲ 35% vs 2024 (€ 29,864) Favourable step	▲ 35%
Retained profit	€ 16,351 Retained profit 2022: € 16,351 First fiscal year in the series	€ 18,374 Retained profit 2023: € 18,374 ▲ 12% vs 2022 (€ 16,351) Favourable step	€ 31,721 Retained profit 2024: € 31,721 ▲ 73% vs 2023 (€ 18,374) Favourable step	€ 2,285 Retained profit 2025: € 2,285 ▼ 93% vs 2024 (€ 31,721) Unfavourable step	▼ 93%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 40,000 Dividend 2025: € 40,000 Unchanged (€ 0) Unchanged
Bank debt	€ 8,179 Bank debt 2022: € 8,179 First fiscal year in the series	€ 1,285 Bank debt 2023: € 1,285 ▼ 84% vs 2022 (€ 8,179) Favourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 1,285) Favourable step	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 36,155 Balance sheet total 2022: € 36,155 First fiscal year in the series	€ 30,654 Balance sheet total 2023: € 30,654 ▼ 15% vs 2022 (€ 36,155) Unchanged	€ 37,973 Balance sheet total 2024: € 37,973 ▲ 24% vs 2023 (€ 30,654) Unchanged	€ 49,170 Balance sheet total 2025: € 49,170 ▲ 29% vs 2024 (€ 37,973) Unchanged	▲ 29%

Key figures of DEPRETZ SEVERINE INFIRMIERE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DEPRETZ SEVERINE INFIRMIERE?

What happened at DEPRETZ SEVERINE INFIRMIERE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Mar 2, 2026 New annual accounts for financial year 2025: profit of € 10,564 (▼ 21% vs 2024). Source: NBB ↗
Dec 14, 2021 New establishment in Celles (lez-Tournai). KBO
2021 SEVERINE DEPRETZ became a director. NBB
Dec 14, 2021 Start of the company according to the CBE. KBO

In short

From € 16,351 profit in 2022 to € 10,564 profit in 2025.

Paid € 16,498 in corporate taxes since 2022.

Best year ever: 2022, with € 16,351 profit.

Paid out € 40,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DEPRETZ SEVERINE INFIRMIERE? We notify you, reason included.

Follow DEPRETZ SEVERINE INFIRMIERE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

SEVERINE DEPRETZ

DEPRETZ SEVERINE INFIRMIERE

Behind DEPRETZ SEVERINE INFIRMIERE is SEVERINE DEPRETZ.

See the full network in the app

Directors

According to the 2025 annual accounts

SEVERINE DEPRETZ

Director

since 2021

Establishments

Establishment units

Physical locations of this company

Registered office

Rue du Palais (POT) 35

7760 Celles (lez-Tournai)

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0778.630.084
VAT number: BE 0778.630.084
Registered office: Rue du Palais (POT) 35, 7760 Celles (lez-Tournai)
Names & denominations: DEPRETZ SEVERINE INFIRMIERE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 14 December 2021
Peppol: Active · Active since 20 Nov 2025
Contact: [email protected] +3247791239

View on CBE Public ↗ Annual accounts (NBB) ↗